Skip to main content
Log in

Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Bellanné-Chantelot C, Chaumarel I, Labopin M, Bellanger F, Barbu V, De Toma C et al. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood 2006; 108: 346–352.

    Article  Google Scholar 

  2. Bock O, Busche G, Koop C, Schroter S, Buhr T, Kreipe H . Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders. J Mol Diagn 2006; 8: 170–177.

    Article  CAS  Google Scholar 

  3. Steimle C, Lehmann U, Temerinac S, Goerttler PS, Kreipe H, Meinhardt G et al. Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F. Ann Hematol 2007; 86: 239–244.

    Article  CAS  Google Scholar 

  4. Bock O, Serinsoz E, Neusch M, Schlue J, Kreipe H . The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders. Br J Haematol 2003; 123: 472–474.

    Article  Google Scholar 

  5. Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L et al. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin Gastroenterol Hepatol 2006; 4: 1283–1291.

    Article  CAS  Google Scholar 

  6. Hussein K, Brakensiek K, Ballmaier M, Bormann M, Gohring G, Buhr T et al. B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 2006; 77: 539–541.

    Article  CAS  Google Scholar 

  7. Zehentner BK, Loken MR, Wells DA . JAK2(V617F) mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders. Am J Hematol 2006; 81: 806–807.

    Article  Google Scholar 

  8. Kralovics R, Teo S-S, Li S, Theocharides A, Buser AS, Tichelli A et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 2006; 108: 1377–1380.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from Deutsche Krebshilfe, Dr Mildred Scheel Stiftung 10-2191 (OB, HK) and Deutsche Forschungsgemeinschaft –DFG BO 1954/1-1 (OB, HK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Kreipe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussein, K., Bock, O., Ballmaier, M. et al. Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis. Leukemia 21, 2566–2568 (2007). https://doi.org/10.1038/sj.leu.2404846

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404846

  • Springer Nature Limited

This article is cited by

Navigation